1.Numerical computation on the scaffolds models with regular square holes using nonlinear fluid-solid-coupling approaches
Ya-Bin ZHAI ; Yu-Hong CUI ; Wen-Jiao LI
Journal of Medical Biomechanics 2010;25(1):4-10
Objective The influencing parameters of solid and fluid computing fields for the scaffolds models with regular square holes were discussed by nonlinear fluid-solid-coupling approaches.The numerical computational resuits of which the models were regarded as both rigid body and non-linear elasticity were compared as well.Method One direct fluid-solid-coupling approach and two indirect fluid-solid-coupling approaches were adopted,and the calculating reliability of three kinds of fluid-solid coupling methods was verified.Rasults The solid-fluidcoupling computational results are obtained in light of 12 kinds of scaffolds models which are constructed by 3 groups of square side length(50,100 and 150 μm)and 4 groups of porosity(61%,65%,77%and 84%).The field parameters of those solid models including stress,strain and displacement and those fluid models including static pressure,velocity,wall shear stress and strain rate are achieved and compared.Conclusion There appear some difference between the results of porous scaffold models as a rigid body and as non-linear elasticity.The different porosity with the same pore radius or the different pore radius with the same porosity would affect the field parameters of solid models and fluid models in varying degrees.
2.Numerical computation on the scaffolds models with regular square holes using nonlinear fluid-solid-coupling approaches
Ya-Bin ZHAI ; Yu-Hong CUI ; Wen-Jiao LI
Journal of Medical Biomechanics 2010;25(1):4-10
Objective The influencing parameters of solid and fluid computing fields for the scaffolds models with regular square holes were discussed by nonlinear fluid-solid-coupling approaches.The numerical computational resuits of which the models were regarded as both rigid body and non-linear elasticity were compared as well.Method One direct fluid-solid-coupling approach and two indirect fluid-solid-coupling approaches were adopted,and the calculating reliability of three kinds of fluid-solid coupling methods was verified.Rasults The solid-fluidcoupling computational results are obtained in light of 12 kinds of scaffolds models which are constructed by 3 groups of square side length(50,100 and 150 μm)and 4 groups of porosity(61%,65%,77%and 84%).The field parameters of those solid models including stress,strain and displacement and those fluid models including static pressure,velocity,wall shear stress and strain rate are achieved and compared.Conclusion There appear some difference between the results of porous scaffold models as a rigid body and as non-linear elasticity.The different porosity with the same pore radius or the different pore radius with the same porosity would affect the field parameters of solid models and fluid models in varying degrees.
4.Additional karyotypic abnormalities analysis in patients with hematological malignancies post-allogeneic hematopoietic stem cell transplantation.
Jia-wei ZHAO ; Wei-hua ZHAI ; Cheng-wen LI ; Qin ZHANG ; Fang-yun XU ; Heng-hua CHEN ; Jin-ya YUE ; Ming-zhe HAN
Chinese Journal of Hematology 2012;33(8):619-622
OBJECTIVETo analyze the karyotype stability in hematological malignancies patients before and after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and its prognostic significance of monitoring.
METHODSThe karyotypes and clinical data of 21 patients with hematological malignancies at the initial diagnosis and at relapse after allo-HSCT were retrospectively reviewed. Chromosome analysis was performed by standard 24 h-cultured method and R banding.
RESULTSKaryotypes at the initial diagnosis and at relapse after allo-HSCT were different in 11 patients (52.38%), including chromosome 1, 3, 6, 12, 17, 21. Numberical abnormalities and structural chromosomal abnormalities always occurs together. The median survival time of relapse of the patients with karyotype changes was significantly shorter than that of patients without a karyotype change (79 d vs 522 d, P = 0.027), and that of the patients with trisomy 6 was also significantly shorter than that of the patients without trisomy 6 (9 d vs 275 d, P = 0.005).
CONCLUSIONKaryotype changes after relapse are associated with the prognosis of allo-HSCT.
Adolescent ; Adult ; Female ; Hematologic Neoplasms ; genetics ; surgery ; Hematopoietic Stem Cell Transplantation ; adverse effects ; methods ; Humans ; Karyotyping ; Male ; Prognosis ; Retrospective Studies ; Young Adult
5.Treatment of primary systemic amyloidosis with the combination of bortezomib and dexamethasone.
Yong-Ping ZHAI ; Hai-Ning LIU ; Ya-Ping YU ; Xiao-Gang ZHOU ; Ping SONG ; Feng LI ; Xue-Wen WANG
Chinese Journal of Hematology 2010;31(5):319-322
OBJECTIVETo evaluate the efficacy and feasibility of bortezomib plus dexamethasone (BD) in patients with primary systemic (AL) amyloidosis.
METHODSEleven AL amyloidosis patients, including four relapsed or progressed after previous therapies and 7 newly diagnosed were treated with BD. Ten patients had two or more organs involved. Precursor protein analysis showed that 1 was κ light chain, 9 λ light chain; 5 patients with positive immunofixation including 1 IgG κ, 3 IgG λ and 1 IgA λ. BD was administered according to standard two-week schedule.
RESULTSEight patients were evaluable, the median number of treatment cycles was 3 (range 1 - 6). Median follow-up duration was 6 months. At least one affected organ response was observed in six patients and median time to organ response was 2 months. Three patients progressed and two of them died. Toxicities were mainly diarrhea, thrombocytopenia, peripheral neuropathy, fatigue and herpes zoster, and 7 evaluable patients who had toxicities were adjusted dosage and 2 of them interrupted therapy. Epilepsia, paralytic ileus, acute cardiac dysfunction, and postural hypotention were occurred in 3 inevaluble patients.
CONCLUSIONBortezomib plus dexamethasone is effective in AL amyloidosis. Adverse events are common, and in some patients are severe.
Amyloidosis ; drug therapy ; Boronic Acids ; therapeutic use ; Bortezomib ; Dexamethasone ; administration & dosage ; Humans ; Multiple Myeloma ; drug therapy
6.Construction of mutant population of differential race of Xa23 resistant to rice bacterial blight and avirulence activity identification of mutants.
Yong-Li ZHOU ; Ya-Jiao PAN ; Wen-Xue ZHAI ; Jian-Long XU ; Qi ZHANG ; Zhi-Kang LI
Chinese Journal of Biotechnology 2005;21(3):486-488
The mutant population of Xanthomonas oryzae pv oryzae strain differential to rice bacterial blight resistance gene Xa23 has been constructed mediated by transposon in vivo . The results of PCR amplification with specific primers and analysis of flanking sequence of mutants indicated that the foreign DNA has been integrated into X. oryzae pv oryzae genome. Four mutants with changed avirulent activity to Xa23 gene have been identified by artificial inoculation. It is possible to clone genes that are required for AvrXa23 avirulence activity using this new strategy.
Bacterial Proteins
;
genetics
;
Base Sequence
;
DNA Transposable Elements
;
Gene Expression Regulation, Plant
;
Genes, Plant
;
Molecular Sequence Data
;
Mutation
;
Oryza
;
genetics
;
microbiology
;
Plant Diseases
;
microbiology
;
Plants, Genetically Modified
;
genetics
;
microbiology
;
Virulence
;
Xanthomonas
;
genetics
;
pathogenicity
;
physiology
7.Comparison between macroscopic identification and DNA barcoding identification of Amomi Fructus.
En-Ai ZHAI ; Wen-Juan MI ; Yang CUI ; Wei-Feng HONG ; Ya-Shun WANG ; Xing-Yu GUO ; Hui-Qin ZOU ; Yong-Hong YAN
China Journal of Chinese Materia Medica 2022;47(17):4600-4608
This study aims to explore the consistency between macroscopic identification and DNA barcoding identification of Amomi Fructus. With the DNA barcoding identification results, we evaluated the reliability of identifying Amomi Fructus quality by combining macroscopic traits with main volatile chemical components. Thirteen batches of Amomi Fructus samples were collected for identification. Firstly, the morphological and sensory characteristics of each sample were observed and recorded according to the standard in Chinese Pharmacopoeia(2020 edition). The 100-fruit weight, longitudinal diameter, transverse diameter, and longitudinal diameter-to-transverse diameter ratio were measured, which correspond to large, solid, and full kernel representing good quality in the sensory evaluation. The odor value detected by electronic nose and major volatile components(borneol, camphor, limonene, and borneol acetate) correspond to the sensory evaluation of strong odor representing good quality. Secondly, DNA barcoding was employed to identify the 13 batches of samples. Finally, clustering analysis was performed for the main volatile components and macroscopic traits, and the identification results were compared with those of DNA barcoding. Except two batches of samples(No.6 and No.10), the macroscopic identification showed the results consistent with those of DNA barcoding, with an identification rate of 84.62%. The clustering results of the content of four volatile chemical components and macroscopic traits were also consistent with the DNA barcoding identification results. DNA barcoding can verify the results of macroscopic identification and provide a scientific basis for the inheritance and development of macroscopic identification. Moreover, the combination of macroscopic traits and chemical components demonstrates higher accuracy in the quality evaluation of Chinese medicinal materials.
Camphanes
;
Camphor/analysis*
;
DNA Barcoding, Taxonomic
;
Drugs, Chinese Herbal/chemistry*
;
Fruit/genetics*
;
Limonene/analysis*
;
Reproducibility of Results
8.The Effect of Immunized Platelet Transfusion Refractoriness on Allo-HSCT Patients with Malignant Hematological Diseases.
Yuan-Ling ZUO ; Ju-Ping ZHAI ; Yong LI ; Min JIANG ; Qing-Ya CUI ; Xiao-Wen TANG ; Yi-Ming ZHAO ; Jian-Ming ZHANG
Journal of Experimental Hematology 2021;29(6):1923-1928
OBJECTIVE:
To investigate the characteristics of platelet antibody in patients with hematological diseases, so as to research the effect of immunized platelet transfusion refractoriness (PTR) on the prognosis of allogeneic hematopoietic stem cell transplantation (allo-HSCT) recepients with malignant hematological diseases patients.
METHODS:
The clinical data of platelet antibody positive patients tested by Capture-P in the First Affiliated Hospital of Soochow University from July 1, 2014 to July 1, 2019 were retrospectively analyzed, including sex, age, disease, platelet transfusion assessments, CD34
RESULTS:
In 5 years, 913 (7.28%) hematologic patients with platelet antibody positive were identified, the detection rate of females (513 cases) were higher than males (400 cases). Among the 913 patients, the antibody positive rates of 520 patients with malignant hematological diseases (acute myeloid leukemia, acute lymphoblastic leukemia and myelodysplastic syndrome) showed significantly statistical different (10.27%, 8.01%, and 7.20%) (P<0.01), and the positive rate of the acute myeloid leukemia of those patients was higher than myelodysplastic syndrome patients(α<0.0125). There were 35 cases diagnosed as immunized PTR before allo-HSCT, the platelet increments, 14 h correct count increment, progression-free survival rate and overall survival rate of those patients were significantly lower than those in negative transfusion effective patients (P<0.01), while the percentage of ABO matching was significantly higher (α<0.0125).
CONCLUSION
The positive rate of platelet antibody identification is high in females and acute myeloid leukemia patients, and immunized PTR caused by antibody is a risk factor for poor prognosis of allo-HSCT in malignant hematological disease patients.
Female
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Leukemia, Myeloid, Acute
;
Male
;
Myelodysplastic Syndromes
;
Platelet Transfusion
;
Retrospective Studies
9.Detection and Analysis of Blood Dexmedetomidine in Drug-Facilitated Cases.
Wen-Ya ZHAI ; Li-Na WU ; Shuo YANG ; Bao-Hua SHEN ; Yan SHI
Journal of Forensic Medicine 2023;39(5):452-456
OBJECTIVES:
To establish a simple and rapid qualitative and quantitative detection method of dexmedetomidine in blood.
METHODS:
Blood was separated on the Allure PFP Propyl liquid chromatography column with isocratic elution after it was precipitated by acetonitrile and filtered. Qualitative and quantitative analysis of dexmedetomidine was performed using positive ion scan mode and multi-reaction monitoring mode.
RESULTS:
The limit of detection of dexmedetomidine in blood was 0.2 ng/mL and the limit of quantification was 0.5 ng/mL. The linearity of the method was good in the range of 0.5-1 000 ng/mL, and the correlation coefficient was greater than 0.99. The accuracy of the method was 90.34%-112.67% and the extraction recovery was 50.05%-91.08%, with no significant matrix effect.
CONCLUSIONS
This method is simple, selective and suitable for the qualitative and quantitative analysis of dexmedetomidine in blood, which can provide a reference for drug-facilitated cases involving dexmedetomidine.
Tandem Mass Spectrometry/methods*
;
Chromatography, High Pressure Liquid/methods*
;
Dexmedetomidine/analysis*
;
Reproducibility of Results
;
Chromatography, Liquid/methods*
10.Bushen Daozhuo Granules for type Ⅲ prostatitis: A multicenter randomized controlled clinical trial.
Da-Lin SUN ; Bin CAI ; Bao-Fang JIN ; Guo-Shou XIA ; Zhi-An TANG ; Wen-Tao YANG ; Qiang ZOU ; Guo-Hong SONG ; Jian-Guo LIU ; Hong-le ZHAO ; Ning DAI ; Jia-Hui WANG ; Ya-Long GU ; Ya-Lin ZHAI
National Journal of Andrology 2017;23(2):164-168
Objective:
To study the safety and efficacy of Bushen Daozhuo Granules (BDG) in the treatment of type Ⅲ prostatitis.
METHODS:
This multicenter randomized controlled clinical trial included 478 patients with type Ⅲ prostatitis, 290 in the trial group and 188 as controls, the former treated with BDG at 200 ml bid and the latter with tamsulosin hydrochloride sustainedrelease capsules at 0.2 mg qd, both for 4 weeks. Before treatment, after 4 weeks of medication, and at 4 weeks after drug withdrawal, we obtained the NIH Chronic Prostatitis Symptom Index (NIHCPSI) scores and compared the safety and effectiveness rate between the two groups of patients.
RESULTS:
Compared with the baseline, the NIHCPSI score was markedly decreased in the control group after 4 weeks of medication (21.42 ± 4.02 vs 15.67 ± 3.65, P < 0.05) but showed no statistically significant difference from that at 4 weeks after drug withdrawal (19.03 ± 3.86) (P>0.05), while the NIHCPSI score in the trial group was remarkably lower than the baseline both after 4 weeks of medication and at 4 weeks after drug withdrawal (10.92 ± 2.06 and 12.91 ± 2.64 vs 21.58 ± 3.67, P < 0.05). The trial group exhibited both a higher rate of total effectiveness and safety than the control (P < 0.05).
CONCLUSIONS
BDG is safe and effective for the treatment of type Ⅲ prostatitis.
Capsules
;
Chronic Disease
;
Delayed-Action Preparations
;
Drugs, Chinese Herbal
;
adverse effects
;
therapeutic use
;
Humans
;
Male
;
Prostatitis
;
drug therapy
;
pathology
;
Sulfonamides
;
adverse effects
;
therapeutic use
;
Tamsulosin
;
Treatment Outcome
;
Urological Agents
;
adverse effects
;
therapeutic use